Nanofiber Implant Delivers Three Drugs, Doubles Survival in Glioblastoma Mice

Researchers at the University of Cincinnati and Johns Hopkins Medicine developed a nanofiber implant that delivers a combination of drugs to treat glioblastoma, a deadly form of brain cancer. In mouse trials, this innovative treatment doubled survival rates compared to standard therapies. This breakthrough offers significant hope for improving outcomes in one of the most challenging cancers to treat.